Martin Laimer

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Thomas R. Pieber, Bruce W. Bode, Young Min Cho et al. · The Lancet Diabetes & Endocrinology · 2019 · 274 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

Dimitra Kiritsi, Kathrin Dieter, Elke Niebergall‐Roth et al. · JCI Insight · 2021 · 80 citations · Full text

Medicine, Dermatology, Immunology +15

Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial

Verena Wally, Alain Hovnanian, Juliette Ly et al. · Journal of the American Academy of Dermatology · 2018 · 69 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Seborrheic keratosis: Reflectance confocal microscopy features and correlation with dermoscopy

Verena Ahlgrimm‐Siess, Theresa Cao, Margaret Oliviero et al. · Journal of the American Academy of Dermatology · 2013 · 64 citations

Medicine, Dermatology, Ophthalmology +12

Novel KIND1 Gene Mutation in Kindler Syndrome With Severe Gastrointestinal Tract Involvement

Elke Sadler, Alfred Klausegger, Wolfgang Muss et al. · Archives of Dermatology · 2006 · 62 citations

Life Sciences, Genetics, Molecular Genetics +14